US75901B1070
US75901B1070
REGENXBIO Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 532.73M EUR | 648.88M EUR | 432.55M EUR | 732.84M EUR |
Enterprise Value | 678.99M EUR | 681.35M EUR | 488.39M EUR | 771.88M EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -2.71x | -- | -- | -- |
Price to Sales | 3.05x | 3.72x | 4.93x | 9x |
Price to Book | 6.09x | 9.04x | 20.52x | 7.13x |
EV/Revenue | 3.89x | 3.9x | 5.56x | 9.48x |
EV/EBITDA | -4.56x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -34.59% | -38.48% | -54.65% | -21.69% |